Literature DB >> 20213822

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times.

Ying Jiao Zhao1, Hwee Lin Wee, Yiong-Huak Chan, Soo Hoon Seah, Wing Lok Au, Puay Ngoh Lau, Emmanuel Camara Pica, Shu Chuen Li, Nan Luo, Louis C S Tan.   

Abstract

This study was carried out to evaluate progression in Parkinson's disease (PD) by analyzing time taken to transit from one Hoehn and Yahr (H&Y) stage to the next stage and to investigate the variables that would be associated with H&Y transition times using a large PD database that contained prospectively collected information. Data were obtained from the movement disorder database of the National Neuroscience Institute in Singapore. Kaplan-Meier (KM) survival analysis was adopted to investigate the time taken to progress through various H&Y stages. Cox regression analysis was used to examine the association between the baseline variables at the entry point of each H&Y stage and the progression to the next stage. A total of 695 patients (mean age: 65.2, male: 57.3%) were studied. Using KM analysis, the median time taken to transit from H&Y stage 1 to 2, 2 to 2.5, 2.5 to 3 were 20, 62, and 25 months, respectively; whereas the median time taken to progress from stage 3 to 4 and 4 to 5 were 24 and 26 months, respectively. Cox regression analysis revealed that older age-at-diagnosis, longer PD duration, and higher Unified Parkinson's Disease Rating Scale (UPDRS) motor scores at baseline were associated with a significantly faster progression through various H&Y stages. Gender and ethnicity were not associated with disease progression. In conclusion, H&Y transition time is a useful measure of disease progression in PD and may be utilized in clinical studies evaluating therapeutic interventions and prognostic factors in PD. 2010 Movement Disorder Society

Entities:  

Mesh:

Year:  2010        PMID: 20213822     DOI: 10.1002/mds.22875

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  44 in total

1.  Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.

Authors:  Sotirios A Parashos; Jordan Elm; James T Boyd; Kelvin L Chou; Lin Dai; Zoltan Mari; John C Morgan; Lewis Sudarsky; Catherine L Wielinski
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

2.  Evaluating the Cost-Effectiveness of an Early Detection of Parkinson's Disease through Innovative Technology.

Authors:  David A Munoz; Mehmet Serdar Kilinc; Harriet B Nembhard; Conrad Tucker; Xuemei Huang
Journal:  Eng Econ       Date:  2017-03-22       Impact factor: 0.861

Review 3.  Palliative Care for Parkinson's Spectrum Disorders: an Emerging Approach.

Authors:  Maya Katz
Journal:  Neurotherapeutics       Date:  2021-01-13       Impact factor: 7.620

4.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.

Authors:  Xiaojun Guan; Min Xuan; Quanquan Gu; Peiyu Huang; Chunlei Liu; Nian Wang; Xiaojun Xu; Wei Luo; Minming Zhang
Journal:  NMR Biomed       Date:  2016-02-08       Impact factor: 4.044

5.  Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.

Authors:  Nir Giladi; Anthony P Nicholas; Mahnaz Asgharnejad; Elisabeth Dohin; Franz Woltering; Lars Bauer; Werner Poewe
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

6.  Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.

Authors:  Ashok Sriram; Herbert E Ward; Anhar Hassan; Sanjay Iyer; Kelly D Foote; Ramon L Rodriguez; Nikolaus R McFarland; Michael S Okun
Journal:  J Neurol       Date:  2012-09-25       Impact factor: 4.849

7.  Identification of distinct blood-based biomarkers in early stage of Parkinson's disease.

Authors:  Yingyan Wu; Qian Yao; Guo-Xin Jiang; Gang Wang; Qi Cheng
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

8.  A Self-Reported Clinical Tool Predicts Falls in People with Parkinson's Disease.

Authors:  Lorena Rosa S Almeida; Maria Elisa Pimentel Piemonte; Helen M Cavalcanti; Colleen G Canning; Serene S Paul
Journal:  Mov Disord Clin Pract       Date:  2021-03-11

9.  Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change.

Authors:  Xuehan Ren; Jeffrey Lin; Glenn T Stebbins; Christopher G Goetz; Sheng Luo
Journal:  Mov Disord       Date:  2021-07-30       Impact factor: 10.338

10.  Relation between Voice Handicap Index (VHI) and disease severity in Iranian patients with Parkinson's disease.

Authors:  Fatemeh Majdinasab; Siamak Karkheiran; Negin Moradi; Gholam Ali Shahidi; Masoud Salehi
Journal:  Med J Islam Repub Iran       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.